3258 articles in this topic
A new review finds kaempferol, a common dietary flavonoid, acts as a senolytic agent and produces dose-dependent hormetic effects tied to aging biology.
FDA-approved methylene blue reduced delirium-like behavior in surgical mice by suppressing neuroinflammation and repairing the blood-brain barrier.
A primate study shows methylene blue treats fatal cerebral malaria and uncovers neutrophil-linked genes as diagnostic biomarkers.
A 4-week-old infant developed severe methemoglobinemia after EMLA cream was applied for circumcision, highlighting hidden dangers of topical anesthetics.
ETH Zurich researchers developed an eco-friendly buccal suction patch that boosts semaglutide and bremelanotide absorption in just 10 minutes.
Researchers critique BPC 157 peptide literature for single-center dominance, missing dose-response data, and unverified anticancer claims.
Researchers rebut claims that BPC 157 promotes tumor growth or neurodegeneration, citing evidence it modulates—not dysregulates—angiogenesis and NO.
The antioxidant peptide Epitalon restores wound healing in high-glucose-damaged retinal cells by curbing oxidative stress and fibrosis.
A 2025 comprehensive review maps how the AMPK/SIRT1/PGC-1α axis controls energy balance and drives neurodegeneration, diabetes, and cardiovascular disease.
A multicenter RCT of 440 patients finds albumin replacement safe but unable to significantly reduce mortality versus standard crystalloid care.
A comprehensive 2025 review covers GBS diagnosis, ICU management, immunotherapy, and emerging biomarkers for intensivists.
The 2025 ISTH guideline update elevates recombinant ADAMTS-13 as the preferred therapy for congenital TTP while maintaining prior immune TTP recommendations.
